Cite
MLA Citation
Kristin K Jørgensen et al.. “Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.” Lancet, vol. 389, no. 10086, 2017, pp. 2304–2316. http://access.bl.uk/ark:/81055/vdc_100046742378.0x00002a